Unofficially Dangerous? Drug Side Effects Title: Supreme Court Rules against Zicam Maker Adam Liptak Author: Source: New York Times, March 23, 2011, http://www.nytimes.com/2011/03/23/ health/23bizcourt.html The Supreme Court unanimously ruled on Tuesday that investors suing a drug company for securities fraud may rely on its failure to disclose scattered reports of adverse affects [sic] from an over-the- counter cold remedy that fell short of statistical significance. The following is an extract from a New York Times article on Zicam: The case involved Zicam, a nasal spray and gel made by Matrixx Initiatives and sold as a homeopathic medicine. From 1999 to 2004, the plaintiffs said, the company received reports that the products very strong momentum" though, by the plaintiffs' calculations, Zicam accounted for about 70% of its sales. ght have caused some users to lose their sense of smell, a condition called anosmia. Matrixx did not disclose the reports and in 2003, the company said it was "poised for growth" and had In the case before the justices, Matrixx Initiatives Inc. v. Siracusano, No. 09-1156, lawyers for Matrixx argued that it should not have been required to disclose small numbers of unreliable reports, which were the only ones available in 2004, they said. They added that the company should face liability for securities fraud only if the reports had been collectively statistically significant. ... Questions 1. This is an unusual situation. Clearly identify (in your own well-chosen words) the two outcomes that are being compared when the words "statistically significant" are used. 2. What is Matrixx claiming? How is their claim related to a Type I Error Rate (false positive rate)?

MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
icon
Related questions
Topic Video
Question

Need the answer to question 1. 

Unofficially Dangerous?
Drug Side Effects
Title:
Supreme Court Rules against Zicam Maker
Adam Liptak
Author:
Source:
New York Times, March 23, 2011, http://www.nytimes.com/2011/03/23/
health/23bizcourt.html
The Supreme Court unanimously ruled on Tuesday that investors suing a drug company for securities
fraud may rely on its failure to disclose scattered reports of adverse affects [sic] from an over-the-
counter cold remedy that fell short of statistical significance.
The following is an extract from a New York Times article on Zicam:
The case involved Zicam, a nasal spray and gel made by Matrixx Initiatives and sold as a homeopathic
medicine. From 1999 to 2004, the plaintiffs said, the company received reports that the products
very strong momentum" though, by the plaintiffs' calculations, Zicam accounted for about 70% of its
sales.
ght have caused some users to lose their sense of smell, a condition called anosmia.
Matrixx did not disclose the reports and in 2003, the company said it was "poised for growth" and had
In the case before the justices, Matrixx Initiatives Inc. v. Siracusano, No. 09-1156, lawyers for Matrixx
argued that it should not have been required to disclose small numbers of unreliable reports, which
were the only ones available in 2004, they said. They added that the company should face liability
for securities fraud only if the reports had been collectively statistically significant.
...
Questions
1. This is an unusual situation. Clearly identify (in your own well-chosen words)
the two outcomes that are being compared when the words "statistically
significant" are used.
2. What is Matrixx claiming? How is their claim related to a Type I Error Rate
(false positive rate)?
Transcribed Image Text:Unofficially Dangerous? Drug Side Effects Title: Supreme Court Rules against Zicam Maker Adam Liptak Author: Source: New York Times, March 23, 2011, http://www.nytimes.com/2011/03/23/ health/23bizcourt.html The Supreme Court unanimously ruled on Tuesday that investors suing a drug company for securities fraud may rely on its failure to disclose scattered reports of adverse affects [sic] from an over-the- counter cold remedy that fell short of statistical significance. The following is an extract from a New York Times article on Zicam: The case involved Zicam, a nasal spray and gel made by Matrixx Initiatives and sold as a homeopathic medicine. From 1999 to 2004, the plaintiffs said, the company received reports that the products very strong momentum" though, by the plaintiffs' calculations, Zicam accounted for about 70% of its sales. ght have caused some users to lose their sense of smell, a condition called anosmia. Matrixx did not disclose the reports and in 2003, the company said it was "poised for growth" and had In the case before the justices, Matrixx Initiatives Inc. v. Siracusano, No. 09-1156, lawyers for Matrixx argued that it should not have been required to disclose small numbers of unreliable reports, which were the only ones available in 2004, they said. They added that the company should face liability for securities fraud only if the reports had been collectively statistically significant. ... Questions 1. This is an unusual situation. Clearly identify (in your own well-chosen words) the two outcomes that are being compared when the words "statistically significant" are used. 2. What is Matrixx claiming? How is their claim related to a Type I Error Rate (false positive rate)?
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Research Design Formulation
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.
Recommended textbooks for you
MATLAB: An Introduction with Applications
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman